We want to ensure you have our latest antimicrobial test data from the USP<51> Antimicrobial Effectiveness Test. The evidence is clear: the hypochlorous acid in Vashe Wound Therapy rapidly kills 99.999% of MRSA, VRE, Acinetobacter baumannii, E.Coli, and other dangerous pathogens in solution in just 15 seconds in laboratory testing with no known microbial resistance. Vashe Wound Therapy with preservative passes the USP<51> Antimicrobial Effectiveness Test, demonstrating rapid effective activity in solution against a broad spectrum of gram-positive, gram-negative, and yeast species:

Time to Kill: 15 seconds   

MRSA: 99.999%

VRE: 99.999%

E.coli: 99.999%

Acinetobacter baumannii: 99.999%

Bacteroides fragilis: 99.999%

Candida albicans: 99.999%

Enterobacter aerogenes: 99.999%

Enterococcus faecium: 99.999%

Haemophilus influenzae: 99.999%

Klebsiella oxytoca: 99.999%

Klebsiella pneumoniae: 99.999%

Micrococcus luteus: 99.999%

Proteus mirabilis: 99.999%

Pseudomonas aeruginosa: 99.999%

Serratia marcescens: 99.999%

Staphylococcus epidermidis: 99.999%

Staphylococcus haemolyticus: 99.999%

Staphylococcus homnis: 99.999%

Staphylococcus saprophyticus: 99.999%

Streptococcus pyogenes: 99.999%

Staphylococcus aureus: 99.998%

Costridium difficile endospores: 99.930%

Journal Articles

It's been a busy few years for Vashe research. In August 2010, Drs. Jeffrey Niezgoda, Peter Sordi, and Michel Hermans published a journal article in Advances in Skin & Wound Care, Evaluation of Vashe in the Clinical Management of Patients with Chronic Wounds 

Conference Posters

The clinical results of Vashe was a topic of conversation at conferences during the last few years as well. Please let us know if you would like any additional information on these presentations. 

"Hypochlorous Acid Enhances the Treatment of Necrotizing Soft-Tissue Wounds"  

Jeffrey A. Niezgoda, MD, FACHM, FAPWCA, FACEP

Clinical Symposium on Advances in Skin & Wound Care

"Hypochlorous acid and its implementation in an acute and chronic care hospital in Port Au Prince Haiti"

G Bohn, MD, FACS; K Eldridge, CNOR, RNFA, CFCN, WCC, BNS; Melodie Blakely, PT, MS, CWS

SAWC Fall

"Helping Haiti Heal: Teaching Wound Care Basics to Haitian and Volunteer Health Care Providers to Hopefully Leave an Enduring Footprint"

G Bohn, MD, FACS; K Eldridge, CNOR, RNFA, CFCN, WCC, BNS; Melodie Blakely, PT, MS, CWS

SAWC Fall

"Randomized Comparison of Hypochlorous Acid to 5% Sulfamylon Solution as Topical Therapy Following Skin Grafting"

KN Foster, MD, MBA; VL Tanner, CRC, MA; KJ Richey, RN, BSN; MA Pressman, PhD; JS Champagne, RN, MA; MD Peck, MD, ScD; DM Caruso, MD

SAWC Spring

There are more journal articles and posters available in the  Vashe Wound Therapy science library as well as videos available in the media gallery.

"We have used Vashe Wound Therapy in our clinic for several years and have realized excellent clinical outcomes on hundreds of patients with a wide variety of very difficult wounds. Our staff and patients welcome the new bottled Vashe offering as a safe, efficacious, and easy-to-use therapy system for utilization in both the clinic and home setting."

Jeffrey A. Niezgoda, MD,

FACHM, FACEP, FAPWCA, Medical Director of Hyperbaric & Wound Care Associates, Milwaukee, WI

"Vashe Wound Therapy is an exciting new alternative technology that demonstrates clinical efficacy for a variety of wounds including post-operative skin graft irrigation as we reported last year. This new packaging format will allow our patients to continue to use Vashe Wound Therapy at home and in other rehabilitation care settings for more effective post operative management of their burns and grafts."

Kevin Foster, MD, MBA, FACS, Co-Director of the Arizona Burn Center at the Maricopa Medical Center, Phoenix, AZ